C07K 5/06052
Val-amino acid
Official title: {Val-amino acid}
C07K5/06052 (Val-amino acid) appears on 368 US grants and 404 published applications in this corpus.
Search patents in C07K- Granted patents
- 368
- Published applications
- 404
- Assignees
- 297
- Inventors
- 1,324
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 12 | 0 |
| 1999 | 16 | 0 |
| 2000 | 14 | 0 |
| 2001 | 11 | 0 |
| 2002 | 8 | 10 |
| 2003 | 8 | 8 |
| 2004 | 6 | 6 |
| 2005 | 2 | 9 |
| 2006 | 6 | 9 |
| 2007 | 2 | 8 |
| 2008 | 5 | 11 |
| 2009 | 9 | 10 |
| 2010 | 10 | 15 |
| 2011 | 15 | 15 |
| 2012 | 3 | 15 |
| 2013 | 17 | 24 |
| 2014 | 14 | 21 |
| 2015 | 14 | 31 |
| 2016 | 20 | 26 |
| 2017 | 15 | 24 |
| 2018 | 12 | 20 |
| 2019 | 19 | 16 |
| 2020 | 16 | 9 |
| 2021 | 6 | 23 |
| 2022 | 9 | 20 |
| 2023 | 10 | 17 |
| 2024 | 9 | 23 |
| 2025 | 10 | 17 |
| 2026 | 9 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Alpha-carbonyl alkenyl ester preparation method therefor and application thereof15 Sep 2026US 12,735,449 B2Jiangxi Normal University
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Linker, antibody-drug conjugate including same and use thereof30 Jun 2026US 12,668,573 B2Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd
- Methods for treating Covid-1916 Jun 2026US 12,653,806 B2Medstar Health, Inc.
- Levorphanol prodrugs and processes for making and using them31 Mar 2026US 12,590,065 B2Zevra Therapeutics, Inc.
- Antibody-drug conjugate comprising anti-cd138 antibody20 Aug 2026US 2026/0241019 A1Taiho Pharmaceutical Co., Ltd.
- Improved linker-payloads for antibody conjugation, pharmaceutical compositions and applications thereof20 Aug 2026US 2026/0241021 A1Obi Pharma, Inc.
- Linker-drug molecule and antibody drug conjugate, preparation method therefor and use thereof13 Aug 2026US 2026/0232825 A1
- Amino acid derivative, preparation method therefor, and pharmaceutical composition for treating hepatitis, comprising same13 Aug 2026US 2026/0234180 A1Prazertherapeutics Inc.
- Flavor-enhancing composition, manufacturing method therefor, and method for enhancing flavor of food product6 Aug 2026US 2026/0223904 A1House Foods Corporation
Most cited
By later US patents
- Heterocyclic self-immolative linkers and conjugates164US 7,375,078 B2Genentech, Inc. · 2008
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Branched peptide linkers136US 6,759,509 B1Bristol-Myers Squibb Company · 2004
- Heterocyclic self-immolative linkers and conjugates134US 7,754,681 B2Seattle Genetics, Inc. · 2010
- Lipid conjugates of therapeutic peptides and protease inhibitors130US 5,554,728 ANeXstar Pharmaceuticals, Inc. · 1996